Jones Financial Companies
VRCA icon

Jones Financial Companies’s Verrica Pharmaceuticals VRCA Stock Holding History

Jones Financial Companies’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178 Hold
26
– – ﹤0.01% 4856
2026
Q1 		$114 Buy
+26
New +$166 ﹤0.01% 4632
2025
Q3 		– Sell
-7
Closed -$38 – 4384
2025
Q2 		$38 Hold
7
– – ﹤0.01% 3981
2025
Q1 		$32 Hold
7
– – ﹤0.01% 3670
2024
Q4 		$51 Hold
7
– – ﹤0.01% 3379
2024
Q3 		$123 Buy
+7
New +$315 ﹤0.01% 2966

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jones Financial Companies's VRCA Position: Q2 2026 in Review

Jones Financial Companies held its Verrica Pharmaceuticals (VRCA) position steady in Q2 2026 at 26 shares worth $178. The position accounts for ﹤0.01% of the portfolio, ranked #4856.

Jones Financial Companies first reported a position in VRCA in Q3 2024 and has held it in 6 quarters since. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Jones Financial Companies held 26 shares of Verrica Pharmaceuticals worth $178 as of Q2 2026.
  • Jones Financial Companies left its Verrica Pharmaceuticals share count unchanged in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4856 holding.
  • Jones Financial Companies first reported a position in Verrica Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.